The role of the histone chaperone SPT6 in mammalian cells is not fully understood. Here, we investigated the involvement of SPT6 in type I interferon (IFN)-induced transcription in murine fibroblasts. In RNA-seq analysis, Spt6 siRNA attenuates about half of~200 IFN-stimulated genes (ISGs), while not affecting housekeeping genes. ISGs with high mRNA induction are more susceptible to Spt6 siRNA than those with lower levels of induction. ChIP analysis shows that SPT6 is recruited to highly inducible, Spt6 siRNA-sensitive ISGs, but not to other siRNA-insensitive ISGs. Furthermore, SPT6 recruitment is abrogated in cells lacking the histone methyltransferase NSD2. In co-IP experiments, SPT6 interacts with NSD2. In summary, SPT6 facilitates IFN-induced transcription, highlighting its critical role in gene activation.
The role of the histone chaperone SPT6 in mammalian cells is not fully understood. Here, we investigated the involvement of SPT6 in type I interferon (IFN)-induced transcription in murine fibroblasts. In RNA-seq analysis, Spt6 siRNA attenuates about half of~200 IFN-stimulated genes (ISGs), while not affecting housekeeping genes. ISGs with high mRNA induction are more susceptible to Spt6 siRNA than those with lower levels of induction. ChIP analysis shows that SPT6 is recruited to highly inducible, Spt6 siRNA-sensitive ISGs, but not to other siRNA-insensitive ISGs. Furthermore, SPT6 recruitment is abrogated in cells lacking the histone methyltransferase NSD2. In co-IP experiments, SPT6 interacts with NSD2. In summary, SPT6 facilitates IFN-induced transcription, highlighting its critical role in gene activation.
Keywords: histone methylation; interferon; interferon stimulated genes; NSD2; SPT6; transcription SPT6 is a conserved histone chaperone that binds to histone H3 and nucleosomes [1, 2] . It interacts with the elongating form of RNA polymerase II (Pol II) that is phosphorylated at serine 2 of the C-terminal domain (CTD) and facilitates transcription in vitro and in vivo [3] [4] [5] [6] [7] [8] . In yeast, Spt6 supports nucleosomal occupancy across the coding region of transcribed genes [9, 10] . In mammalian cells, SPT6 interacts with the histone methyltransferase SETD2 which catalyzes methylation of histone H3 at lysine 36 (H3K36) [11] [12] [13] . The H3K36 methylation is linked to the prevention of cryptic transcription from within the coding region [13] [14] [15] . Recently, SPT6 was also shown to interact with the histone demethylase KDM6A, which demethylates H3K27, and to negatively regulate polycomb-mediated gene repression, resulting in enhanced expression of genes important for myogenic differentiation [16] . Furthermore, Gerard et al. [17] , showed that SPT6 interacts with the HIV-1integrase cofactor, LEDGF/p75 along with IWS1, and plays a role in the maintenance of HIV-1 latency.
We have been working on interferon (IFN)-stimulated transcription as a model to study signal-induced transcription. IFN activates the JAK/STAT signaling Abbreviations BMDM, bone marrow derived macrophage; IFN, interferon; ISG, interferon stimulated genes; TES, transcription end site; TSS, transcription start site.
pathway and induces many IFN-stimulated genes (ISGs), culminating in the establishment of innate immunity against pathogen infection [18] . We previously showed that ISG transcription occurs largely as a result of de novo assembly of Pol II complexes at the transcription start site (TSS), followed by the recruitment of BRD4 and P-TEFb, as well as NELF/DSIF that together facilitate mRNA elongation [19] . In addition, BRD4 helps to recruit the histone methyltransferase NSD2 that methylates H3 at K36 [20] [21] [22] . Recruitment of NSD2 was important for HIRA dependent deposition of the histone variant H3.3 at ISGs [20] Here, we provide evidence that SPT6 complexes with NSD2 during ISG transcription and boosts transcription of highly inducible ISGs.
Methods

Cells
Mouse embryonic fibroblasts (MEFs), spontaneously transformed during passage of primary culture were established from wild-type (WT) or NSD2 À/À mice as described [20, 21] .
MEFs and NIH3T3 cells were grown in Dulbucco's minimal essential medium (DMEM) containing 10% FBS or donor bovine serum. Cells were treated with mouse recombinant IFN-b (100 unitsÁmL À1 , PBL Interferon Source) for indicated times. Bone marrow-derived macrophages (BMDM) were prepared from 8-16 weeks old C57BL/6 mice as described [23] . Mice were maintained in the NICHD animal facility as approved by the NICHD animal care and user committee and described in the ASP (#14-077, #17-044). BMDMs were stimulated with Poly IC (100 lgÁmL À1 ;
Amersham Biosciences, Piscataway, NJ, USA) for 6 h.
Immunocytochemistry
Mouse embryonic fibroblasts (WT and NSD2 À/À ) were seeded onto coverslips in six-well plates, fixed in 3% paraformaldehyde in PBS for 25 min at 37°C, and then washed with PBS. The cells were permeabilized in 0.2% Triton X-100 in PBS for 5 min, washed with PBS, and blocked for 30 min at room temperature in 5% FBS in PBS. . For bioinformatic analysis, RNA-seq reads were aligned to the Mus musculus transcriptome (UCSC version mm10) using TopHat2. We used FastQC and Qualimap 2 [24] for inspecting the quality of the RNA-seq data. To estimate the expression levels, the numbers of short reads aligned to all genes were counted using the htseq-count command, from the HTSeq package [25] . For normalization of the count values and differential expression analysis, we used the R/Bioconductor package DESeq2 [26] . The heat maps showing the different expression levels in different samples were generated in R, using the pheatmap package. The GEO database accession number for the sequence data is GSE97302.
Results
IFN stimulation prompts accumulation of SPT6 on ISGs
To test whether SPT6 was recruited to ISGs, ChIPqPCR was performed with chromatin from NIH3T3 cells for the Ifit1 gene, a typical ISG, important for IFN's anti-viral activity [27] . Figure 1A depicts a schematic diagram of the 8.7 kb murine Ifit1 gene. SPT6 accumulation was examined for three regions, near the TSS (blue), within the coding region (red) and near the end of the gene (green) at different time points after IFN stimulation (0, 1, 3, 6, 12, 24, and 48 h). Data in Fig. 1B show that SPT6 was rapidly recruited to the gene, reaching the maximum at 3-6 h and declining thereafter. The gene body and transcription end site (TES) showed much greater accumulation relative to the TSS area. Since SPT6 is known to bind to Pol II [3] [4] [5] , we next examined accumulation of Pol II phosphorylated at serine 2 of the CTD (Pol II-2P). ChIP data in Fig. 1C found that this elongating form of Pol II also rapidly accumulated on the gene after IFN treatment, displaying a very similar spatial pattern and kinetics to those of SPT6. ChIP-qPCR was also performed for Pol II phosphorylated at serine 5 (Pol II-5P), the initiation form of Pol II. As shown in Fig. 1D , Pol II-5P accumulation also increased after IFN stimulation, but shows the peak accumulation earlier than SPT6. In addition, Pol II-5P showed a different pattern of spatial occupancy, in that the highest occupancy was found at the TSS region. As seen in [28] . However, the IFN-unresponsive housekeeping gene Gtf2b did not show accumulation of SPT6 after IFN treatment. These data indicate that SPT6 is recruited to ISGs upon transcription activation, presumably along with RNA elongation.
Recruitment of SPT6 to ISGs depends on the interaction with NSD2
We previously reported that NSD2 was recruited to the ISGs after IFN treatment, observed most prominently in the gene body, but weakly at the TSS. We further noted that IFN-induced Pol II accumulation was markedly reduced in NSD2 À/À cells [20] . This suggested the possibility that NSD2 is required for SPT6 recruitment. Results of ChIP-qPCR in Fig. 2A showed that SPT6 recruitment was drastically reduced in NSD2 À/À cells relative to wild-type cells. However, broadly localized in the nucleus in both types of cells (Fig. 2C) . Similarly, NSD2 localized exclusively to the nucleus, as evidenced by DAPI stain. Importantly, much of NSD2 and SPT6 colocalized within the nucleus in WT cells, indicating a close physical proximity of the two factors. These results raised the possibility that SPT6 interacts with NSD2. To this end, we performed coimmunoprecipitation (Co-IP) assays using cells expressing FLAG-tagged NSD2. Anti-FLAG antibody-precipitated materials were immunoblotted with antibodies against SPT6, Pol II-2P and an elongation factor P-TEFb (CYCLIN T1). As shown in Fig. 2D , SPT6 was present in the FLAG-NSD2 precipitates, which also contained Pol II-2P and P-TEFb. SPT6 was not found in control IgG precipitates. The amount of precipitated SPT6 was proportional to the endogenous SPT6 shown in the input lane. These data indicate that SPT6 is incorporated into elongation complexes and moves through the ISG coding regions upon IFN stimulation.
Spt6 siRNA attenuates ISG induction
Although SPT6 was clearly incorporated into the transcription machinery on ISGs, it remained unclear whether SPT6 helps or hinders overall ISG mRNA expression. SPT6 is reported to promote or suppress target gene expression [8, 16, 17] . In addition, we previously noted that some elongation factors, such as P-TEFb stimulate ISG expression, while others such as NELF/DSIF inhibit it [19] . To determine whether SPT6 regulates ISG mRNA expression positively or negatively, we tested the effect of siRNA-based Spt6 knockdown. Cells were transfected with two siRNAs for 48 h and endogenous SPT6 protein levels were assessed by western blotting. As shown in Fig. 3A left, both Spt6 siRNAs (siRNA-#1, siRNA-#2) led to a significant reduction in SPT6 levels. Combining both siRNAs did not further reduce SPT6 levels. In contrast, negative control siRNA (NC) did not reduce SPT6 levels. Quantification of SPT6 band intensity showed that the two siRNAs knocked down SPT6 by~60-70% (Fig. 3A, right) . Immunostaining experiments showed that SPT6 protein was distributed throughout the nucleus (except nucleoli) and that SPT6 signals were diminished specifically by Spt6 siRNA (Fig. S1 ). As expected, Spt6 mRNA levels were strongly reduced by Spt6 siRNAs (Fig. 3B ). Cells treated with Spt6 siRNAs appeared healthy and grew at a rate similar to cells with control siRNA under these conditions. Cells transfected with these siRNAs were then treated with IFN and ISG expression was measured for Ifit1 and Stat1 by qRT-PCR (Fig. 3C) . We found that induction of these ISGs was substantially attenuated by either of the Spt6 siRNAs, as compared to NC. Gtf2b levels, tested as a control, did not show a significant reduction. To further assess the effect of Spt6 knockdown, we tested Spt6 siRNA on fresh BMDM stimulated by Poly IC. Poly IC is a synthetic viral RNA mimic which activates endogenous IFNb and ISG induction [18] . As shown in Fig. 3E , Spt6 siRNA attenuated induction of Ifit1 and Mx1, another typical anti-viral ISG, by about 50%. Thus, SPT6 positively regulates ISG transcript expression in fibroblasts and macrophages.
Genome-wide RNA-seq identifies SPT6-regulated ISGs
To determine whether SPT6 regulates genome-wide ISG induction, RNA-seq analysis was carried out in NIH3T3 cells. Under basal conditions without IFN stimulation, global RNA expression patterns were very similar between control siRNA and Spt6 siRNA samples, suggesting that Spt6 knockdown had a minimum impact on housekeeping genes under these conditions (Fig. S2) . Figure 4A depicts scatter plot analysis to compare untreated vs. 4 h of IFN treatment marking differentially expressed genes in red. Red dots over the base line represent genes upregulated by IFNs. We operationally defined ISGs as genes showing more than threefold increase after 4 h of IFN treatment and a Benjamini-Hochberg adjusted p-value cutoff of 0.05 (5% false discovery rate). As shown by the pie chart in Fig. 4B , 213 genes were identified as ISGs (blue), whereas 44 genes were downregulated after IFN treatment (pink, see the list of ISGs in Table S1 ). The scatter plot in Fig. 4C compares expression levels in control and Spt6 knockdown cells. Red dots mark ISGs whose mRNA counts were at least 30% lower in the Spt6 knockdown cells relative to control cells. As summarized in the pie chart in Fig. 4D , about half of ISGs were downregulated by Spt6 siRNA, namely dependent on SPT6 (green), while the rest of ISGs were not affected by the siRNA, that is, SPT6-Independent (Orange). Hierarchical clustering of these genes are shown in Fig. S3 . ISGs dependent or independent of SPT6 are also presented in Tables S2  and S3 . None of the ISGs were upregulated by Spt6 siRNA. GO-analysis by the Enrichr program revealed that SPT6-dependent ISGs were enriched with the categories such as innate resistance to pathogens and Type I IFN signaling, whereas SPT6-independent ISGs were related to locomotion, taxis, chemotaxis etc, which did not overlap with the categories for downregulated genes Fig. 4E , indicating that Spt6 influence is more dominant over some, but not other aspects of IFN action.
To gain additional insight into SPT6 regulation of ISG transcription, we compared average RPKM values of RNA peaks between ISGs downregulated or unchanged by Spt6 siRNA. Data in Fig. 4E found that ISGs sensitive to Spt6 siRNA were induced at higher levels than those unchanged by the siRNA (p < 0.01). qRT-PCR was performed to confirm RNA-seq data for genes identified as downregulated or unchanged by Spt6 siRNA in NIH3T3 cells. We found in Fig. 4F that indeed, ISGs such as Mx1, Oas1a, downregulated by Spt6 siRNA were induced at high levels. However, those ISGs unaffected by the siRNA were induced at much more modest levels (Fig. 4G ). Induction levels for these genes seemed less than threefold. Nevertheless, fold induction was greater than 3 in the RNA-seq analysis (Fig. S4A) . Together, SPT6 differentially upregulates mRNA induction of various ISGs. These results are consistent with the previous reports that SPT6 exerts varying effects on transcription [16] . Next, since SPT6 has been shown to control cryptic intragenic transcription and splicing, we examined average RNA peaks over the coding genes genome-wide [2, 5] . Data in Fig. S4B showed no major difference between control and SPT6 siRNA-treated cells with and without IFN stimulation, suggesting that intragenic control of transcript synthesis is not significantly affected by Spt6 siRNA under these conditions.
SPT6 is selectively recruited to SPT6-dependent ISGs
The above results indicate that there are two groups of ISGs, one dependent on SPT6 for transcription, the other largely independent of SPT6. The former group expressed on average higher levels of transcripts than the latter. So, it was critical to determine whether SPT6 was recruited only to SPT6-dependent ISGs, or whether it was recruited to all ISGs, irrespective of SPT6 dependence. ChIP-qPCR was performed to examine SPT6 binding to SPT6-dependent ISGs (Oas1a and Mx1) and SPT6-independent ISGs (Gadd45g, Adar, Socs1; Table S4 ). SPT6 was vigorously recruited to SPT6-dependent genes after IFN stimulation, with high signals on TES (TES/gene bodies) (Fig. 5A ). This spatial pattern of SPT6 binding was similar to that of Ifit1 and Stat1 (Figs 1 and 2 ). SPT6 recruitment on Oas1a and Mx1 was abrogated in the absence of NSD2, as observed for Ifit 1 and Stat1. In contrast, on SPT6-independent genes, little to no SPT6 recruitment was detected in response to IFN. The levels of SPT6 binding were generally lower, and remained unchanged before and after IFN stimulation with no TES/gene body-preferred binding. These results were reproduced by several additional ChIP-qPCR experiments using chromatin prepared from separate cell samples (Fig. S5 and Table S4 ). Thus, SPT6 is recruited mostly to SPT6-dependent ISGs, but not to SPT6-independent ISGs. These results support the idea that SPT6 enhances ISG mRNA expression by augmenting ISG transcription.
Discussion
In this communication, we report that SPT6 boosts mRNA expression of some, but not all ISGs. ChIPqPCR data provided a plausible mechanism by which SPT6 augments ISG expression, in that SPT6 was recruited selectively to SPT6-dependent ISGs, but not to independent genes. These results support the role for SPT6 in increasing ISG transcription of some ISGs. ISGs whose expression was dependent on SPT6 generally expressed higher amounts of mRNA than SPT6-independent ISGs. We also show that the spatial and temporal pattern of SPT6 recruitment was very similar to that of Pol II-2P. It is thus reasonable to assume that SPT6 comes in to play during ISG elongation to increase mRNA outputs. Furthermore, no SPT6 recruitment was detected in NSD2 À/À cells, pointing to a link between SPT6 and NSD2. We show additional evidence for this link: first, co-IP experiments found that SPT6 interacts with NSD2. Second, the large majority of SPT6 and NSD2 colocalized with each other in the nucleus. It is possible that SPT6 is recruited to the ISGs through NSD2. Consistent with this interpretation, we previously reported that NSD2 is recruited to ISGs after IFN treatment, exhibiting similar gene body-preferred accumulation as SPT6 [20] . In that study, we also showed that NSD2 recruitment prompted the deposition of the histone H3.3 in ISGs, suggesting that ISG transcription triggers chromatin exchange in ISGs in an NSD2-dependent manner [20] . In yeast, Spt6 is required for the maintenance of nucleosomes in the coding regions of highly transcribed genes [2, 9, 10] . Although it is not clear whether in mammalian cells SPT6 also controls nucleosome maintenance, it may be tempting to envisage that SPT6, along with NSD2, plays a role in H3.3 histone replacement during active transcription.
The interaction of SPT6 with NSD2 is interesting, since SPT6 has been shown to interact with another histone methyltransferase, SETD2 [13] . Both NSD2 and SETD2, members of the SET2 family of histone methyltransferases, catalyze methylation of histone H3K36: dimethylation by NSD2 and trimethylation by SETD2 [21, 29, 30] . Although NSD2 and SETD2 have the conserved catalytic SET domain, only NSD2 has several additional domains, such as PWWP, PHD and HMG [29, 30] . NSD2 plays an important role in embryonic development in mice, required for formation of various organs, including heart [22] .
Under our experimental conditions, Spt6 siRNA did not increase expression of any ISGs, that is, it only reduced some ISG expression, indicating that SPT6 facilitates, but does not inhibit transcriptional induction. Although Spt6 siRNA inhibited some ISGs, it had no measurable effect on constitutively expressed, housekeeping genes. These data are consistent with a differential role of SPT6 in regulating transcription and indicate that SPT6 has a larger impact on induced transcription as opposed to steady state transcription. Our findings are reminiscent of several earlier reports showing that SPT6 has a greater impact on nucleosome occupancy at highly transcribed genes relative to those expressed at lower levels, illustrating that SPT6 elicits differential effects on target genes, preferentially affecting genes with robust transcription [9, 10] . Interestingly, SPT6-dependent, highly induced ISGs were enriched with GO categories of host resistance against pathogens, while more moderately induced, SPT6-independent genes were enriched with other categories of innate immunity such as taxis, indicating that SPT6 is required for an intense and immediate transcriptional response critical for immediate elimination of infectious pathogens.
As for the mechanism, while SPT6 facilitated ISG transcript elongation in this system, its action may be more complex and diverse. Supporting this notion, SPT6 is reported to regulate splicing, suppression of cryptic transcription in the gene body and suppression of anti-sense transcription [2, 5, 9] . SPT6 also takes part in setting chromatin in the promoter for transcription [10] . It is conceivable that SPT6 exerts its effect on ISG transcription through multiple mechanisms.
It should be noted here that we did not achieve 100% depletion of SPT6 by the siRNA mediated knockdown. It seems clear that our results reflect partial reduction rather than complete removal of SPT6. It is thus likely that SPT6 has a role in regulating constitutively expressed genes, and that it could affect a greater percentage of ISGs than observed here, had SPT6 been fully removed. Although the present report provides compelling evidence for the role of SPT6 in ISG induction, more complete understanding of SPT6 awaits investigation of a Spt6 knockout.
In conclusion, SPT6 plays an integral role in signal activated transcription and boosts overall mRNA outputs of its target genes. Fig. S2 . Effect of Spt6 siRNA on gene expression. Fig. S3 . Diverse gene expression changes for ISGs upon interferon treatment. Fig. S4 . Normalized total RNA counts. Fig. S5 . Recruitment of SPT6 to SPT6 dependent (Oas1a and Mx1) and independent ISGs (Gadd45g, Adar, Socs1). Table S1 . IFN-b stimulated gene list. Table S2 . The list of ISGs that were affected by siRNAmediated SPT6 knockdown. Table S3 . The list of ISGs that were not affected by SPT6 knockdown. Table S4 . ChIPÀqRTÀPCR primer list used in the ChIP assay.
